Cyrus J. Lawrence’s Bristol-Myers Squibb BMY Stock Holding History

Cyrus J. Lawrence’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,100	Closed	-$62K	–	63
2024 Q4	$62K	Hold	1,100	–	–	0.01%	109
2024 Q3	$56K	Hold	1,100	–	–	0.01%	115
2024 Q2	$45K	Hold	1,100	–	–	0.01%	115
2024 Q1	$59K	Buy	+1,100	New	+$56K	0.01%	106
2023 Q3	$63K	Hold	1,100	–	–	0.02%	92
2023 Q2	$70K	Hold	1,100	–	–	0.02%	91
2023 Q1	$76K	Sell	1,100 -211	-16%	-$14.9K	0.02%	92
2022 Q4	$94K	Buy	1,311 +11	+0.8%	+$829	0.03%	86
2022 Q3	$92K	Sell	1,300 -600	-32%	-$43.5K	0.02%	86
2022 Q2	$146K	Hold	1,900	–	–	0.04%	90
2022 Q1	$139K	Buy	+1,900	New	+$128K	0.03%	97

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cyrus J. Lawrence's BMY Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 1,100 shares — an estimated $62K sold.

Cyrus J. Lawrence first reported a position in BMY in Q1 2022 and held it in 11 quarters. The position peaked at $146K in Q2 2022. 2,485 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Cyrus J. Lawrence reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Cyrus J. Lawrence sold 1,100 Bristol-Myers Squibb shares in Q1 2025, an estimated $62K.
Cyrus J. Lawrence first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 11 quarters.
Cyrus J. Lawrence's Bristol-Myers Squibb position peaked at $146K in Q2 2022.
2,485 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.